BioCanRx is happy to introduce the 17 undergraduate students chosen from across Canada through a competitive application process to be part of our Summer Studentship Program. The program’s goal is to inspire the next generation of highly qualified personnel to pursue research in cancer immuno-oncology. Undergraduate students receive funding to conduct research with BioCanRx’s network… Read more »
Category: News
Innovative approaches to strategic training
By Heather Blumenthal Training the next generation of health researchers is part of the mandate for any research funding organization, and BioCanRx is no exception. It does all of the standard things that many research funding organizations do – such as supporting students at all stages as well as post-doctoral fellows. BioCanRx does… Read more »
Out in the real world
By Heather Blumenthal Clinical trials – especially the double-blind, randomized sort – are considered the gold standard in the development of new treatments and therapies, and for good reason. They provide the data on safety and efficacy that enable these treatments to take the final jump to actual use in the clinic. But… Read more »
Where Are They Now: Sarwat Khan
At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy. BioCanRx is invested in… Read more »
Treating the untreatable: How and why Canada’s CAR-T cancer network was built
“We realized we have the people, we have the infrastructure, we just have to put the parts together to build a CAR-T network.” The story of how and why Canada’s CAR T-cell network was built. Read about this life-saving therapy and the point of care network funded by BioCanRx and our partners in this… Read more »
BioCanRx-funded Researchers Publish Results from CAR T CSEI Project
BioCanRx researchers Dean Fergusson, Justin Presseau, Natasha Kekre, Harold Atkins, Kednapa Thavorn, Rob Holt, Manoj Lalu, and patient representative Terry Hawrysh have recently published results in two medical journals from their BioCanRx-funded project, “Getting better Outcomes with Chimeric Antigen Receptor T-cell therapy (GO–CART): A BioCanRx Research Excelerator to Safely and Effectively Translate CAR T-Cell Therapy… Read more »
When health research saves lives – and creates economic growth to boot!
By Heather Blumenthal Knowledge translation has become a key concept in the research world – but as usually applied, it stands for taking research discoveries from the lab to the clinic – literally, the journey from bench to bedside. There’s another way to think about knowledge translation, one that involves translating lab discoveries… Read more »
Where Are They Now: Piriya Yoganathan
At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy. BioCanRx is invested in… Read more »
BioCanRx Welcomes New Board Members
The BioCanRx network is pleased to announce the appointment of five new members to its Board of Directors. The new Board members include: Dr. Josée Brisebois, Head of Medical, Incyte Canada / Medical Affairs with oversight of Clinical & Regulatory Affairs Doreen Hume, Partner, Audit & Assurance, Deloitte Canada Antonia Palmer, Co-Founder at… Read more »
Bringing immunotherapy to the bedside
By Heather Blumenthal There’s no question – immunotherapy works. Numerous research studies, many of them funded by BioCanRx, have shown that taking a cancer patient’s own T cells, “supercharging” them in the lab to recognize and fight the patient’s own tumour and using a virus to deliver them to the cancer site is… Read more »
